Journal
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
Volume 6, Issue 2, Pages 173-185Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/EGH.11.105
Keywords
hepatocellular carcinoma; hepatologist; interventional radiologist; medical oncologist; multidisciplinary team; natural history; outcomes; surgical oncologist; targeted therapy; treatment
Categories
Funding
- Bayer Healthcare Pharmaceuticals
- Onyx Pharmaceuticals, Inc.
- Bristo-Myers Squibb, Inc.
Ask authors/readers for more resources
It has long been appreciated that hepatocellular carcinoma (HCC) is a complex disease. HCC is typically preceded by liver cirrhosis, which is itself caused by various types of hepatitis of both viral and nonviral etiologies. Thus, the treatment of patients with HCC requires multiple healthcare professionals, including hepatologists, medical oncologists, surgical oncologists, transplantation surgeons, diagnostic radiologists, pathologists, nurses, nurse practitioners and interventional radiologists. These specialists should meet regularly to review patients' progress, ensure that treatments are individualized for each patient and agree on next steps. We review case presentations provided by the authors to illustrate the benefits and advantages of the multidisciplinary team matrix in the management of patients with HCC, including the effects of this treatment technique on patient outcome, survival and quality of life.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available